Nurses approve contract agreement with Michigan Medicine

Three-year agreement includes pay raises, paid parental leave, commitment to patient safety, quality care

Author | Mary Masson

Nurses represented by the University of Michigan Professional Nurses Council (UMPNC) have ratified a three-year contact with Michigan Medicine, the academic medical center of the University of Michigan.

The competitive employment agreement provides a commitment to patient safety and high-quality care, according to leaders from Michigan Medicine and the UMPNC, which represents the 5,700 registered nurses at University of Michigan hospitals, clinics and other health care facilities.

“This ratification is good news for the entire Michigan Medicine community: our nurses, our patients and all of our staff. We are grateful to all who worked tirelessly to bargain a fair agreement,” said David Spahlinger, M.D., president of the University of Michigan Health System and executive vice dean for clinical affairs of the U-M Medical School. 

“Our top priority is to ensure our patients receive the highest quality of care. Our nurses are critical to that goal, and this contract reflects our interest in moving forward together. We believe this agreement will help us retain and recruit excellent nurses.”

The contract includes guidelines for staffing that continue Michigan Medicine’s commitment to excellent patient care, while allowing for flexibility to meet patient needs.

In August, Michigan Medicine was ranked #5 in the nation by U.S. News & World Report. These Honor Roll rankings are achieved, in part, by excellent nurse to patient ratios. Michigan Medicine’s ratios are in the top 2 percent of all hospitals in the country.

The contract includes salary raises of 3 to 4 percent, representing an increase from the past four years when those increases were about 1 percent.

The contract also includes: 

•Increased funding for tuition reimbursement and professional development that will ensure maintenance of nursing Magnet status, the highest honor in nursing granted to about 6 percent of U.S. hospitals.

•Maintenance of current health insurance and retirement benefits

•Changes to eliminate payroll system inaccuracies

•Reductions in mandatory overtime

•Paid maternal/parental leave program that includes six weeks of paid leave for physiological recovery from birth of a child and six weeks of paid parental leave to employees after a birth, adoption or foster care and guardianship, which matches benefits recently granted to non-union University employees

Michigan Medicine will continue to work with the UMPNC in implementing the new contract.

“Over the months of bargaining, we stressed our support and respect for nurses and worked to resolve workplace issues that needed improvement,” Spahlinger said. 

“This is a significant milestone, and we look forward to working with our nurses as we continue our efforts to bring the best healthcare possible to our patients and communities across the state.”

More information can be found at www.uofmhealth.org/nursing-negotiations

 

About Michigan Medicine: At Michigan Medicine, we create the future of healthcare through the discovery of new knowledge for the benefit of patients and society; educate the next generation of physicians, health professionals and scientists; and serve the health needs of our citizens. We pursue excellence every day in our three hospitals, 125 clinics and home care operations that handle more than 2.3 million outpatient visits a year.

Michigan Medicine includes the top ranked U-M Medical School and the University of Michigan Health System, which includes the C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, University Hospital, the Frankel Cardiovascular Center and the Rogel Cancer Center. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $470 million.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
Health Lab
Mother-son heart bond: Woman relives congenital heart journey through newborn
A mother relives congenital heart journey through newborn.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
If they don't give up, how can I give up?
Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
From Patients to Progress: Advancing Autoimmune Research
Today on The Fundamentals, our guest is Dr. Michelle Kahlenberg, an Associate Professor of Internal Medicine and Dermatology, the Giles Bole and Dorothy Mulkey Research Professor of Rheumatology and the Vice Chair for Basic and Translational Research in Internal Medicine. Her clinical work is centered on the care of patients with lupus, including those with refractory skin disease. In addition to running her lab, she's an active member of the Immunology Training Program and has received national recognition for her research.